Physician

Amanda Marie Koroly Godfrey, M.D.

According to 2025 Medicare claims, Amanda Godfrey, M.D. (NPI: 1225246242) practices pulmonary disease in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is HENRY FORD HEALTH SYSTEM (NPI: 1790868297; TIN: 38-1357020) and primary practice location at 48202-2608. Godfrey is affiliated with the McAuley Health Partners ACO, LLC (ACO ID: A4588) and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Godfrey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 285 traditional Medicare patients, billed 672 HCPCS/CPT codes, and received $37,643 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 1,313 prescription claims across 218 beneficiaries totaling $529,312 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 297 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $139,419 to $37,643. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $169,186 and ending at $529,312. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $32,193 to $8,890.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	635	1,804	$139,419
2016	715	1,766	$135,398
2017	619	1,727	$128,180
2018	528	1,366	$103,337
2019	465	1,211	$88,863
2020	304	811	$64,967
2021	411	929	$64,697
2022	337	784	$51,383
2023	365	760	$44,907
2024	285	672	$37,643

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	183	803	$169,186
2016	191	1,042	$326,270
2017	216	1,258	$492,996
2018	206	1,359	$677,154
2019	211	1,462	$699,818
2020	220	952	$507,389
2021	192	907	$328,103
2022	274	1,548	$660,494
2023	288	1,418	$547,333
2024	218	1,313	$529,312

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	174	610	$28,422
2016	349	1,257	$73,175
2017	430	1,363	$104,823
2018	547	1,943	$120,396
2019	512	1,733	$113,022
2020	250	908	$58,565
2021	37	403	$31,220
2022	23	337	$16,185
2023	N/R	290	$10,201
2024	13	297	$11,394

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	38	117	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	38	44	$71
94618	Test for exercise-induced lung stress	50	50	$14
94729	Test to examine how well the lungs exchange gases	93	96	$6
94010	Test to measure expiratory airflow and volume	114	118	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	164	6,420	$131,267
Xolair	Omalizumab	20	560	$65,700
Dupixent Pen	Dupilumab	17	476	$57,265
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	86	2,940	$44,242
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	62	2,220	$33,639

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7608	Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram	N	N/R	11	$3,074
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	22	$1,476
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	16	$1,218
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	20	$941
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	13	44	$933

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Amanda Marie Koroly Godfrey, M.D.?

Tedicare shows public-source Medicare data for Amanda Marie Koroly Godfrey, M.D. (NPI 1225246242), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Marie Koroly Godfrey, M.D. have ACO affiliation data?

Amanda Marie Koroly Godfrey, M.D. is shown with ACO affiliation data for McAuley Health Partners ACO, LLC (MSSP, ACO ID A4588) and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Amanda Marie Koroly Godfrey, M.D.?

Amanda Marie Koroly Godfrey, M.D. is linked to HENRY FORD HEALTH SYSTEM (billing NPI 1790868297) in the available physician profile data.

Does Amanda Marie Koroly Godfrey, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.